These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 975053)

  • 1. Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice.
    Berd DA; Mitchell MS
    Cancer Res; 1976 Nov; 36(11 Pt 1):4119-24. PubMed ID: 975053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
    Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
    Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Corynebacterium parvum on cellular and humoral antitumoral immune effector mechanisms.
    Mantovani A; Tagliabue A; Vecchi A; Spreafico F
    Eur J Cancer (1965); 1976 Feb; 12(2):113-23. PubMed ID: 1083341
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunomodulation by Corynebacterium parvum. 1. Variable effects on anti-sheep erythrocyte antibody responses.
    Ghaffar A; Sigel MM
    Immunology; 1978 Nov; 35(5):685-93. PubMed ID: 363603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis and reversal of the inhibition of cytophilic antibody receptors produced by antibody.
    Mitchell MS; Mokyr MB; Goldwater DJ
    Cancer Res; 1975 May; 35(5):1121-7. PubMed ID: 1078991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
    Rao VS; Mitchell MS
    J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
    Fuji H; Mihich E
    Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immune responses in vitro. II. Simultaneous generation of cytotoxic lymphocyte responses to two sets of alloantigens of limited cross-reactivity.
    Peavy DL; Pierce CW
    J Immunol; 1975 Dec; 115(6):1515-20. PubMed ID: 1184965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.
    Lee KC; Berry D
    J Immunol; 1977 May; 118(5):1530-40. PubMed ID: 323353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different fractions of Corynebacterium parvum on the cytotoxic T-cell response to alloantigens in mice.
    Lichtenstein A; Tuttle R; Cantrell J; Zighelboim J
    J Natl Cancer Inst; 1982 Aug; 69(2):495-501. PubMed ID: 6213807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies on the enhancement of the antibody response in vitro by C. parvum.
    Slijivíc VS; Brown CA; Watson SR
    Dev Biol Stand; 1977 Apr 13-15; 38():147-52. PubMed ID: 608502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.
    Miyata H; Himeno K; Miake S; Nomoto K
    Immunology; 1981 Oct; 44(2):305-10. PubMed ID: 7298070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
    Orsini F; Pavelic Z; Mihich E
    Cancer Res; 1977 Jun; 37(6):1719-26. PubMed ID: 66985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Corynebacterium parvum on the course of a Listeria monocytogenes infection in normal and congenitally athymic (nude) mice.
    Ruittenberg EJ; van Noorle Jansen LM
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):197-205. PubMed ID: 808049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Einstein AB; Fass L; Fefer A
    Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
    Scott MT; Warner SL
    Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine.
    Murahata RI; Mitchell MS
    J Natl Cancer Inst; 1982 Sep; 69(3):607-12. PubMed ID: 6981020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cells involved in the modification of the in vitro immune response by Corynebacterium parvum (C. parvum).
    Liacopoulos-Briot M; Lambert F; Halpern B
    Dev Biol Stand; 1977 Apr 13-15; 38():215-21. PubMed ID: 344096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.